Search results
Results from the WOW.Com Content Network
The INR is typically used to monitor patients on warfarin or related oral anticoagulant therapy. The normal range for a healthy person not using warfarin is 0.8–1.2, and for people on warfarin therapy an INR of 2.0–3.0 is usually targeted, although the target INR may be higher in particular situations, such as for those with a mechanical ...
INR self-monitoring is a medical kit that is used by patients both on long-term and on lifetime anti-coagulation therapy to measure their INR (International Normalized Ratio) levels themselves at your premises without going to a clinic. People who self-monitor their INR levels use a portable INR monitor as in a clinic.
The SAMe-TT 2 R 2 score [1] [2] is a clinical prediction rule to predict the quality of vitamin K antagonist anticoagulation therapy as measured by time in therapeutic INR range (TTR) (VKA e.g. warfarin). [3]
Targeted temperature management (TTM), previously known as therapeutic hypothermia or protective hypothermia, is an active treatment that tries to achieve and maintain a specific body temperature in a person for a specific duration of time in an effort to improve health outcomes during recovery after a period of stopped blood flow to the brain. [1]
Warfarin necrosis is also different from another drug eruption associated with warfarin, purple toe syndrome, which usually occurs three to eight weeks after the start of anticoagulation therapy. No report has described this disorder in the immediate postpartum period in patients with protein S deficiency.
Originally therapeutic recompression was done using air as the only breathing gas, and this is reflected in several of the tables detailed below. However, work by Yarbrough and Behnke [ 7 ] showed that use of oxygen as a treatment gas is usually beneficial and this has become the standard of care for treatment of DCS. [ 3 ]
The combination of argatroban and warfarin may raise the INR to greater than 5.0 without a significant increased risk of bleeding complications. [6] One solution to this problem is to measure the chromogenic factor X level. A level < 40–45% typically indicates that the INR will be therapeutic (2–3) when the argatroban is discontinued.
Therapeutic inertia (also known as clinical inertia [1]) is a measurement of the resistance to therapeutic treatment for an existing medical condition.It is commonly measured as a percentage of the number of encounters in which a patient with a condition received new or increased therapeutic treatment out of the total number of visits to a health care professional by the patient.